Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki disease.

Charlotte A Lee1

  • 1Empire General Life Assurance Corporation, PO Box 310, Shawnee Mission, KS 66201-0310, USA.

Journal of Insurance Medicine (New York, N.Y.)
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Kawasaki disease is a leading cause of acquired heart disease in children. This review examines its pathogenesis, complications, treatment, and prognosis using an 18-year-old case study.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A New High Throughput Screening Platform for Cell Encapsulation in Alginate Hydrogel Shows Improved Hepatocyte Functions by Mesenchymal Stromal Cells Co-encapsulation.

Frontiers in medicine·2018
Same author

Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine.

Journal of molecular medicine (Berlin, Germany)·2018
Same author

Cryopreserved neonatal hepatocytes may be a source for transplantation: Evaluation of functionality toward clinical use.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2018
Same author

Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives.

Cell transplantation·2016
Same author

Human papillomavirus (HPV) and cervical cancer.

Journal of insurance medicine (New York, N.Y.)·2013
Same author

Isolated systolic hypertension.

Journal of insurance medicine (New York, N.Y.)·2010
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Area of Science:

  • Pediatric Cardiology
  • Immunology

Background:

  • Kawasaki disease is the primary cause of acquired heart disease in children in the US and Japan.
  • Early diagnosis and treatment are crucial to prevent cardiac complications.

Observation:

  • Presents a case study of an 18-year-old insurance applicant with Kawasaki disease.
  • Highlights the long-term implications of the disorder.

Findings:

  • Reviews the pathogenesis, detailing the inflammatory processes involved.
  • Discusses common and rare complications, including coronary artery aneurysms.
  • Outlines current treatment strategies and their effectiveness.

Implications:

  • Emphasizes the importance of understanding Kawasaki disease for long-term patient management.
  • Informs prognosis and risk stratification for affected individuals.
  • Underscores the need for continued research into Kawasaki disease etiology and treatment.